help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuryshev, Y. A.
Right arrow Articles by Ritchie, A. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuryshev, Y. A.
Right arrow Articles by Ritchie, A. K.

Endocrinology, Vol 136, 3925-3935, Copyright © 1995 by Endocrine Society


ARTICLES

Corticotropin-releasing hormone stimulation of Ca2+ entry in corticotropes is partially dependent on protein kinase A

YA Kuryshev, GV Childs and AK Ritchie
Department of Physiology and Biophysics, University of Texas Medical Branch, Galveston 77555-0641, USA.

The modulation of membrane excitability and cytosolic Ca2+ levels by corticotropin-releasing hormone (CRH), (Bu)2cAMP (dBcAMP), and forskolin was examined in enriched populations of cultured rat anterior pituitary corticotropes. CRH (2 or 20 nM), dBcAMP (1 and 5 mM), and forskolin (10 microM) caused a long lasting membrane depolarization accompanied by the onset of cell firing in quiescent cells or by increased firing frequency in spontaneously active cells. All three substances also increased cytosolic Ca2+ levels by increasing the frequency and amplitude of cytosolic Ca2+ transients. These results are consistent with a previous report on human corticotrope tumor cells demonstrating that CRH-induced action potentials lead to enhancement of Ca2+ uptake through voltage-dependent Ca2+ channels. Preincubation with (N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), an inhibitor of cAMP-dependent protein kinase A, did not inhibit the CRH- induced depolarization, but attenuated the CRH-induced increase in action potential frequency. H-89 inhibited CRH-induced changes in cytosolic Ca2+ by 69% in spontaneously active cells and by 83% in quiescent cells. In contrast, H-89 completely abolished the effects of dBcAMP and forskolin on membrane potential and cytosolic Ca2+ levels. It is concluded that activation of protein kinase A mediates all of the response to dBcAMP and forskolin, but only a portion of the response to CRH. The portion of the response to CRH that is resistant to H-89 is mediated by a cAMP-independent mechanism.


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
E. W. Hillhouse and D. K. Grammatopoulos
The Molecular Mechanisms Underlying the Regulation of the Biological Activity of Corticotropin-Releasing Hormone Receptors: Implications for Physiology and Pathophysiology
Endocr. Rev., May 1, 2006; 27(3): 260 - 286.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. K. Lee and A. Tse
Dominant Role of Mitochondria in Calcium Homeostasis of Single Rat Pituitary Corticotropes
Endocrinology, November 1, 2005; 146(11): 4985 - 4993.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. Seino and T. Shibasaki
PKA-Dependent and PKA-Independent Pathways for cAMP-Regulated Exocytosis
Physiol Rev, October 1, 2005; 85(4): 1303 - 1342.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
V. Mynard, O. Latchoumanin, L. Guignat, J. Devin-Leclerc, X. Bertagna, B. Barre, J. Fagart, O. Coqueret, and M. G. Catelli
Synergistic Signaling by Corticotropin-Releasing Hormone and Leukemia Inhibitory Factor Bridged by Phosphorylated 3',5'-Cyclic Adenosine Monophosphate Response Element Binding Protein at the Nur Response Element (NurRE)-Signal Transducers and Activators of Transcription (STAT) Element of the Proopiomelanocortin Promoter
Mol. Endocrinol., December 1, 2004; 18(12): 2997 - 3010.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. T. Hinkle, E. Donnelly, D. B. Cody, S. Samuelsson, J. S. Lange, M. B. Bauer, M. Tarnopolsky, R. J. Sheldon, S. C. Coste, E. Tobar, et al.
Activation of the CRF 2 receptor modulates skeletal muscle mass under physiological and pathological conditions
Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E889 - E898.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. S. Kostic, M. Tomic', S. A. Andric, and S. S. Stojilkovic
Calcium-independent and cAMP-dependent Modulation of Soluble Guanylyl Cyclase Activity by G Protein-coupled Receptors in Pituitary Cells
J. Biol. Chem., May 3, 2002; 277(19): 16412 - 16418.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Tomic, T.-a. Koshimizu, D. Yuan, S. A. Andric, D. Zivadinovic, and S. S. Stojilkovic
Characterization of a Plasma Membrane Calcium Oscillator in Rat Pituitary Somatotrophs
J. Biol. Chem., December 10, 1999; 274(50): 35693 - 35702.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. A. Kuryshev, G. M. Brittenham, H. Fujioka, P. Kannan, C.-C. Shieh, S. A. Cohen, and A. M. Brown
Decreased Sodium and Increased Transient Outward Potassium Currents in Iron-Loaded Cardiac Myocytes : Implications for the Arrhythmogenesis of Human Siderotic Heart Disease
Circulation, August 10, 1999; 100(6): 675 - 683.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
D. Engler, E. Redei, and I. Kola
The Corticotropin-Release Inhibitory Factor Hypothesis: A Review of the Evidence for the Existence of Inhibitory as Well as Stimulatory Hypophysiotropic Regulation of Adrenocorticotropin Secretion and Biosynthesis
Endocr. Rev., August 1, 1999; 20(4): 460 - 500.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. J. Rossant, R. D. Pinnock, J. Hughes, M. D. Hall, and S. McNulty
Corticotropin-Releasing Factor Type 1 and Type 2{alpha} Receptors Regulate Phosphorylation of Calcium/Cyclic Adenosine 3',5'-Monophosphate Response Element-Binding Protein and Activation of p42/p44 Mitogen-Activated Protein Kinase
Endocrinology, April 1, 1999; 140(4): 1525 - 1536.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
Y. Aoki, Y. Iwasaki, M. Katahira, Y. Oiso, and H. Saito
Regulation of the Rat Proopiomelanocortin Gene Expression in AtT-20 Cells. I: Effects of the Common Secretagogues
Endocrinology, May 1, 1997; 138(5): 1923 - 1929.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. Shipston, J. S. Kelly, and F. A. Antoni
Glucocorticoids Block Protein Kinase A Inhibition of Calcium-activated Potassium Channels
J. Biol. Chem., April 19, 1996; 271(16): 9197 - 9200.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. A. Andric, T. S. Kostic, M. Tomic', T.-a. Koshimizu, and S. S. Stojilkovic
Dependence of Soluble Guanylyl Cyclase Activity on Calcium Signaling in Pituitary Cells
J. Biol. Chem., January 5, 2001; 276(1): 844 - 849.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society